focus -WSS

focus

author：hotspot 2025-09-30 17:28:42 - browse：8

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Wikipedia

WSS

Headspace, Meta partner to launch VR meditation app for Quest

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Headspace, Meta partner to launch VR meditation app for Quest

UnitedHealth quietly bought dozens of outpatient centers

explore

focus

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How to bring more disabled researchers into academia

BioMarin wins approval for gene therapy to treat hemophilia A

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Medical records are filled with copy

Supreme Court rules employers must be more accommodating of religious observance

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

DIEP, the 'gold standard' of breast reconstruction, is under threat

How to bring more disabled researchers into academia

entertainment

UnitedHealth wins $3.3 billion takeover of Amedisys

The problem with charging patients to message their doctors

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Headspace, Meta partner to launch VR meditation app for Quest

Brazil's Jair Bolsonaro is barred from running for office until 2030

Belarusian journalist sentenced to 4 years in prison as crackdown continues

explore

Wikipedia

entertainment

entertainment